International Journal of Cardiology Cardiovascular Risk and Prevention最新文献

筛选
英文 中文
Dyslipidemia and cerebral atrophy among health check-up individuals: A cross-sectional study
IF 1.9
International Journal of Cardiology Cardiovascular Risk and Prevention Pub Date : 2025-03-08 DOI: 10.1016/j.ijcrp.2025.200394
Xiaoying He , Jingyi Xiao , Yan Wang , Christopher Reid , Dan Xu , Hua Hong
{"title":"Dyslipidemia and cerebral atrophy among health check-up individuals: A cross-sectional study","authors":"Xiaoying He ,&nbsp;Jingyi Xiao ,&nbsp;Yan Wang ,&nbsp;Christopher Reid ,&nbsp;Dan Xu ,&nbsp;Hua Hong","doi":"10.1016/j.ijcrp.2025.200394","DOIUrl":"10.1016/j.ijcrp.2025.200394","url":null,"abstract":"<div><h3>Objective</h3><div>To examine the association between dyslipidemia and cerebral atrophy in Chinese health check-up population.</div></div><div><h3>Methods</h3><div>67,526 participants underwent routine health check-ups at the health management center of the First Affiliated Hospital of Sun Yat-Sen University (FAH-SYSU) in Guangzhou for two years (2022-2023) in this cross-sectional study. Cerebral atrophy was determined by expert physicians based on non-contrast scans of Head Magnetic Resonance Imaging (MRI), Magnetic Resonance Angiography (MRA) and/or Head Computed Tomography (CT). The levels of Total Cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglyceride (TG) were measured and classified by quartiles into four categories, respectively. The multivariable logistic regression model was used to obtain the odds ratios (ORs) and 95% confidence intervals (CIs).</div></div><div><h3>Results</h3><div>A total of 1,661 participants were included with ages from 18 to 93 years. Among 1,661 participants, 121 (7.28%) had cerebral atrophy. On multivariate analysis, TC and LDL-C were not associated with cerebral atrophy, although TC and LDL-C were lower in the subgroup with cerebral atrophy.</div></div><div><h3>Conclusions</h3><div>This cross-sectional study conducted in China is the first to identify that health check-up examinees with cerebral atrophy had lower levels of TC and LDL-C raising the possible association between lower levels of TC and LDL-C with cerebral atrophy, and possible cognitive dysfunction. Future study is planned to overcome the existing limitation and address the lack of statistically significant association between TC and LDL-C levels with cerebral atrophy and possible dementia.</div></div>","PeriodicalId":29726,"journal":{"name":"International Journal of Cardiology Cardiovascular Risk and Prevention","volume":"25 ","pages":"Article 200394"},"PeriodicalIF":1.9,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143601852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends in mortality due to ischemic heart diseases among patients with Alzheimer's disease in the United States from 1999 to 2020
IF 1.9
International Journal of Cardiology Cardiovascular Risk and Prevention Pub Date : 2025-03-07 DOI: 10.1016/j.ijcrp.2025.200390
Muzamil Akhtar , Hanzala Ahmed Farooqi , Rayyan Nabi , Javed Iqbal , Sabahat Ul Ain Munir Abbasi , Muhammad Rashid , Syed Khurram Mushtaq Gardezi , David P. Ripley , Raheel Ahmed
{"title":"Trends in mortality due to ischemic heart diseases among patients with Alzheimer's disease in the United States from 1999 to 2020","authors":"Muzamil Akhtar ,&nbsp;Hanzala Ahmed Farooqi ,&nbsp;Rayyan Nabi ,&nbsp;Javed Iqbal ,&nbsp;Sabahat Ul Ain Munir Abbasi ,&nbsp;Muhammad Rashid ,&nbsp;Syed Khurram Mushtaq Gardezi ,&nbsp;David P. Ripley ,&nbsp;Raheel Ahmed","doi":"10.1016/j.ijcrp.2025.200390","DOIUrl":"10.1016/j.ijcrp.2025.200390","url":null,"abstract":"<div><h3>Background</h3><div>Ischemic heart diseases (IHD) and Alzheimer's Disease (AD) significantly contribute to mortality in aging population. Understanding mortality trends where these conditions overlap is crucial for developing targeted interventions for vulnerable populations.</div></div><div><h3>Methods</h3><div>We analyzed CDC WONDER mortality data from 1999 to 2020 for individuals aged ≥45 years. IHD and AD mortality were identified using ICD-10 codes I20-I25 and G30, respectively. Age-adjusted mortality rates (AAMR) per 100,000 were calculated, and trends were analyzed by gender, race, region, place of death and state. Joinpoint regression was used to calculate annual percentage changes (APC) with 95 % confidence intervals (CI).</div></div><div><h3>Results</h3><div>A total of 171,080 deaths were attributed to IHD in individuals with AD from 1999 to 2020. The AAMR decreased from 10.6 in 1999 to 4.1 in 2020, with a significant decline between 2004 and 2014 (APC: −7.73; 95 % CI: −8.42 to −7.24). Females exhibited higher overall AAMR compared to males (Females: 6.8 vs. Males: 6.4). Individuals of Non-Hispanic (NH) White ancestry had the highest AAMR (6.8), followed by those of NH Black (6.5) and Hispanic ancestry (5.9). The West region reported the highest AAMR at 7.9, while the Midwest had the lowest at 6.3. Oklahoma recorded the highest state-level AAMR (10.9), while Utah had the lowest (3.2).</div></div><div><h3>Conclusions</h3><div>IHD mortality in individuals with AD declined significantly, with disparities by gender, race, and geography. These findings underscore the need for tailored public health approaches to address the evolving burden of IHD in AD patients.</div></div>","PeriodicalId":29726,"journal":{"name":"International Journal of Cardiology Cardiovascular Risk and Prevention","volume":"25 ","pages":"Article 200390"},"PeriodicalIF":1.9,"publicationDate":"2025-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143580117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The associations between circulating amino acids and arterial aneurysms and dissection: A bidirectional Mendelian randomization study
IF 1.9
International Journal of Cardiology Cardiovascular Risk and Prevention Pub Date : 2025-03-07 DOI: 10.1016/j.ijcrp.2025.200388
Xiaodong Li , Yarong Ma , Qiulin Jiang , Huizhi Zhan , Xiaolei Sun
{"title":"The associations between circulating amino acids and arterial aneurysms and dissection: A bidirectional Mendelian randomization study","authors":"Xiaodong Li ,&nbsp;Yarong Ma ,&nbsp;Qiulin Jiang ,&nbsp;Huizhi Zhan ,&nbsp;Xiaolei Sun","doi":"10.1016/j.ijcrp.2025.200388","DOIUrl":"10.1016/j.ijcrp.2025.200388","url":null,"abstract":"<div><h3>Background</h3><div>Circulating amino acid levels can be altered in arterial aneurysms and dissection, but the relationships between them is unclear. The present study investigated the causal relationship between circulating amino acid levels and arterial aneurysms and dissection via bidirectional two-sample Mendelian randomization (MR).</div></div><div><h3>Methods</h3><div>A bidirectional two-sample MR analysis was used. Forward analysis was performed with amino acid levels as the exposure and arterial aneurysms and dissection as outcomes. Reverse analysis was performed with arterial aneurysms and dissection as exposures and circulating amino acid levels as outcomes. MR data were analyzed using five analytical methods: the inverse-variance weighted (IVW), MR‒Egger, weighted median, simple, and weighted methods. IVW was used as the main analytical method, and the other methods were used for supplementary analyses. Heterogeneity was assessed using Cochran's Q test, and horizontal pleiotropy was assessed using intercepts from MR‒Egger regression. The genome-wide association study (GWAS) data for circulating amino acids were obtained from the IEU open GWAS database and the GWAS Catalog database. The GWAS data for arterial aneurysms and dissection were obtained from the Finngen consortium database version R10.</div></div><div><h3>Results</h3><div>The tyrosine level was negatively correlated with other aneurysms (P = 0.00211, OR: 0.57, 95 % CI: 0.40, 0.82). Aortic dissection decreased the circulating glycine level (P = 0.00168, OR: 0.98, 95 % CI: 0.98, 0.99).</div></div><div><h3>Conclusion</h3><div>Through bidirectional MR analysis, we found that tyrosine level was negatively correlated with other aneurysms and that aortic dissection reduced circulating glycine. Our findings support a possible interaction between circulating amino acid levels and arterial aneurysms and dissection.</div></div>","PeriodicalId":29726,"journal":{"name":"International Journal of Cardiology Cardiovascular Risk and Prevention","volume":"25 ","pages":"Article 200388"},"PeriodicalIF":1.9,"publicationDate":"2025-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143601871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rehospitalization, mortality and associated variables in primary care patients with heart failure and preserved ejection fraction after first hospitalization
IF 1.9
International Journal of Cardiology Cardiovascular Risk and Prevention Pub Date : 2025-03-07 DOI: 10.1016/j.ijcrp.2025.200391
Victoria Cendrós , Mar Domingo , Elena Navas , Miguel Ángel Muñoz , Antoni Bayés-Genís , José María Verdú-Rotellar
{"title":"Rehospitalization, mortality and associated variables in primary care patients with heart failure and preserved ejection fraction after first hospitalization","authors":"Victoria Cendrós ,&nbsp;Mar Domingo ,&nbsp;Elena Navas ,&nbsp;Miguel Ángel Muñoz ,&nbsp;Antoni Bayés-Genís ,&nbsp;José María Verdú-Rotellar","doi":"10.1016/j.ijcrp.2025.200391","DOIUrl":"10.1016/j.ijcrp.2025.200391","url":null,"abstract":"<div><h3>Introduction</h3><div>There is a paucity of studies providing insights into the progression of primary care patients with heart failure and preserved ejection fraction (HFpEF).</div></div><div><h3>Objetive</h3><div>To investigate the characteristics associated with mortality and rehospitalizations in primary care patients with heart failure and preserved ejection fraction (HFpEF), previously hospitalized.</div></div><div><h3>Methods</h3><div>Retrospective cohort study that included primary care patients with previous heart failure (HF) hospitalization and ejection fraction ≥50 of 328 primary care centers of Catalonia. Demographic, comorbidities, clinical, and treatment variables were collected. Outocomes: Mortality and HF rehospitalization. Adjusted Cox regression models were performed.</div></div><div><h3>Results</h3><div>Study included 2895 patients. Mean age was 77(SD 9.7) years, 57 % were female. Mean follow up was 2.0[1.0–9.0] years. A total of 864(29.8 %) patients died, 831(28.7 %) were hospitalized. Mortality was associated with male sex(HR 1.26, 95 % CI 1.06–1.49), age &gt;75 years(HR 2.76, 95 % CI 2.24–3.39), Charlson Index(HR 2.03, 95 % CI 1.21–3.42), body mass index(BMI) ≤30 kg/m<sup>2</sup>(HR 1.44, 95 % CI 1.22–1.69) and loop diuretics(HR 1.36, 95 % CI 1.11–1.65); hemoglobin levels(HR 0.87, 95 % CI 95 % 0.82–0.91) were protective. HF rehospitalization was associated with male sex(HR 1.14, 95 % CI 1.03–1.33), age &gt;75 years(HR 1.37, 95 % CI 1.17–1.61), atrial fibrillation(HR 1.44, 95 % CI 1.25–1.67), and loop diuretics(HR 1.37, 95 % CI 1.15–1.63). Hemoglobin(HR 0.91, 95 % CI 0.87–0.95) were protective.</div></div><div><h3>Conclusion</h3><div>High proportion of HFpEF patients were hospitalized or died at 5 years follow up. Comorbidities, demographic, analytical and treatment variables played a relevant role as prognostic factors.</div></div>","PeriodicalId":29726,"journal":{"name":"International Journal of Cardiology Cardiovascular Risk and Prevention","volume":"25 ","pages":"Article 200391"},"PeriodicalIF":1.9,"publicationDate":"2025-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143601872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of sleep duration with hypertension in young and middle-aged adults: A systematic review and meta-analysis
IF 1.9
International Journal of Cardiology Cardiovascular Risk and Prevention Pub Date : 2025-03-07 DOI: 10.1016/j.ijcrp.2025.200387
Lei Yang , Fang-Xiao Hu , Kun Wang , Zhi-Zheng Wang , Jie Yang
{"title":"Association of sleep duration with hypertension in young and middle-aged adults: A systematic review and meta-analysis","authors":"Lei Yang ,&nbsp;Fang-Xiao Hu ,&nbsp;Kun Wang ,&nbsp;Zhi-Zheng Wang ,&nbsp;Jie Yang","doi":"10.1016/j.ijcrp.2025.200387","DOIUrl":"10.1016/j.ijcrp.2025.200387","url":null,"abstract":"<div><h3>Background</h3><div>Hypertension is a primary risk factor for cardiovascular and cerebrovascular diseases. A number of studies have suggested that sleep duration play an important role in the development of hypertension. Hypertension in young and middle-aged individuals is characterized by low awareness and treatment rates, increasing the risk of adverse events. To further elucidate the relationship between sleep duration and hypertension risk in young and middle-aged individuals, we conducted a meta-analysis.</div></div><div><h3>Methods</h3><div>This study searched PubMed, Embase, and the Cochrane Library from January 2003 to November 5, 2023. Data analysis was performed using STATA 17. Using Q test and I2-statistic, heterogeneity test for the included studies was conducted. Potential small-sample effects were evaluated based on the symmetry of funnel plots, and publication bias in included studies was evaluated using Egger's test.</div></div><div><h3>Results</h3><div>Data analysis of sleep duration was conducted for 16 studies, which revealed that both long sleep duration (OR, 1.10; 95 % CI, 1.05–1.15) and short sleep duration (RR: 1.10, 95 % CI: 1.05 to 1.15) were associated with hypertension in young and middle-aged individuals, particularly in Asian populations.</div></div><div><h3>Conclusions</h3><div>This meta-analysis revealed an association between sleep duration (short [&lt;7 h] and long [≥9 h]) and the development of hypertension in young and middle-aged adults, particularly in Asian populations. Sleep is a behavior that can be modified. Clinicians and health professionals should be encouraged to intensify efforts to promote healthy sleep for all and reduce the occurrence of high blood pressure in young and middle-aged individuals.</div></div>","PeriodicalId":29726,"journal":{"name":"International Journal of Cardiology Cardiovascular Risk and Prevention","volume":"25 ","pages":"Article 200387"},"PeriodicalIF":1.9,"publicationDate":"2025-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143580116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using eosinophil response to predict cardiovascular outcomes in patients with ST- elevation myocardial infarction who undergo primary percutaneous coronary intervention
IF 1.9
International Journal of Cardiology Cardiovascular Risk and Prevention Pub Date : 2025-03-06 DOI: 10.1016/j.ijcrp.2025.200383
Joyce Lim , Trent Williams , Lucy Murtha , Nishani Mabotuwana , Conagh Kelly , Doan Ngo , Andrew Boyle
{"title":"Using eosinophil response to predict cardiovascular outcomes in patients with ST- elevation myocardial infarction who undergo primary percutaneous coronary intervention","authors":"Joyce Lim ,&nbsp;Trent Williams ,&nbsp;Lucy Murtha ,&nbsp;Nishani Mabotuwana ,&nbsp;Conagh Kelly ,&nbsp;Doan Ngo ,&nbsp;Andrew Boyle","doi":"10.1016/j.ijcrp.2025.200383","DOIUrl":"10.1016/j.ijcrp.2025.200383","url":null,"abstract":"<div><h3>Objective</h3><div>Eosinophils have been implicated in mediating the inflammatory response after ST-elevation myocardial infarction (STEMI), but its role as a biomarker predicting major adverse cardiovascular events (MACE) remains unclear. We aimed to evaluate the predictive value of eosinophil response on 30-day and 1-year MACE post primary percutaneous coronary intervention (PCI) after STEMI.</div></div><div><h3>Methods</h3><div>Single centre retrospective cohort study of STEMI patients undergoing PCI. Eosinophil response was defined as the change in peripherally circulating eosinophils cell count at admission minus 48 h post primary PCI. Primary endpoints were 30-day and 1-year MACE. Receiver operating characteristic (ROC) curves were created to identify optimal cut-off predicting MACE. Multivariate logistic regression analyses were used to determine if the ROC cut-off was an independent predictor of MACE.</div></div><div><h3>Results</h3><div>Of the 366 patients in this study (median age 61 years [53.0–71.0]; 267 males [73 %]), 41 patients (11.2 %) and 78 patients (21.3 %) developed MACE at 30-days and 1-year. The optimal ROC curve cut-off predicting MACE was an eosinophil response of greater than −0.05 × 10^9/L (ΔEos &gt; −0.05). It had a sensitivity, specificity, and positive and negative predictive value of 83, 39, 6 and 98 % for 30-day MACE, and 74, 39, 19 and 88 % for 1-year MACE. An ΔEos &gt; −0.05 change was associated with a threefold higher likelihood of MACE at 30-days (<em>OR</em> 3.1<em>, 95 % CI</em> 1.04–9.07<em>, p=</em>0.042), but not 1-year</div></div><div><h3>Conclusion</h3><div>An eosinophil response of −0.05 × 10^9L at 48 h following primary PCI post STEMI is highly sensitive at predicting 30-day MACE, and in its absence, holds a high negative predictive value.</div></div>","PeriodicalId":29726,"journal":{"name":"International Journal of Cardiology Cardiovascular Risk and Prevention","volume":"25 ","pages":"Article 200383"},"PeriodicalIF":1.9,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143601870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lipid-lowering prescription patterns after a non-fatal acute coronary syndrome: A retrospective cohort study
IF 1.9
International Journal of Cardiology Cardiovascular Risk and Prevention Pub Date : 2025-03-06 DOI: 10.1016/j.ijcrp.2025.200385
Cristina Gavina , Daniel Seabra Carvalho , Marta Afonso-Silva , Inês Costa , Ana Sofia Freitas , Mariana Canelas-Pais , Nuno Lourenço-Silva , Tiago Taveira-Gomes , Francisco Araújo
{"title":"Lipid-lowering prescription patterns after a non-fatal acute coronary syndrome: A retrospective cohort study","authors":"Cristina Gavina ,&nbsp;Daniel Seabra Carvalho ,&nbsp;Marta Afonso-Silva ,&nbsp;Inês Costa ,&nbsp;Ana Sofia Freitas ,&nbsp;Mariana Canelas-Pais ,&nbsp;Nuno Lourenço-Silva ,&nbsp;Tiago Taveira-Gomes ,&nbsp;Francisco Araújo","doi":"10.1016/j.ijcrp.2025.200385","DOIUrl":"10.1016/j.ijcrp.2025.200385","url":null,"abstract":"<div><h3>Background</h3><div>After an acute atherosclerotic cardiovascular event, high-intensity lipid-lowering therapy (LLT) is needed to reduce recurrence risk. This study aimed to describe LLT prescription patterns and LDL-C levels change after non-fatal acute coronary syndrome (ACS) events and to determine if the recommended goals for LDL-C levels were achieved.</div></div><div><h3>Methods</h3><div>Retrospective cohort study using electronic health records (EHR) of Unidade Local de Saúde de Matosinhos between 2015 and 2023. Participants were adults aged 40–80 years, with a non-fatal ACS hospitalization between 2016 and 2022 (index date); ≥1 general practice appointment in the three years before ACS; and one-year follow-up post-ACS. Sub-analyses focused on gender, age (&lt;and ≥65 years), and whether patients met LDL-C control (55 mg/dL) at one-year post-ACS.</div></div><div><h3>Results</h3><div>Of 544 patients, 270 (49.6 %) were under 65 years, and 164 (30.1 %) were females. Before the ACS, 71.1 % of men and 56.7 % of women had no previous LLT prescription and younger patients showed poorer LDL-C control (132(IQR 64)mg/dL) than older patients (102(IQR 50)mg/dL). One-year post-ACS, only 11.3 % of males and 8.5 % of females met LDL-C target. The proportion of patients without LLT decreased from 66.7 % at baseline to 13.6 % post-ACS. High-intensity LLT prescriptions increased from 2.4 % to 16.5 %, while moderate-intensity LLT remained predominant (65.8 %). Still, 89.5 % of patients had uncontrolled LDL-C levels.</div></div><div><h3>Conclusion</h3><div>Despite initiating/intensifying LLT, one year after ACS most patients did not achieve LDL-C goals. This indicates a significant gap in guideline implementation in clinical practice.</div></div>","PeriodicalId":29726,"journal":{"name":"International Journal of Cardiology Cardiovascular Risk and Prevention","volume":"25 ","pages":"Article 200385"},"PeriodicalIF":1.9,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143580118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Digital self-assessment: A new and innovative way for identifying cardiovascular risks
IF 1.9
International Journal of Cardiology Cardiovascular Risk and Prevention Pub Date : 2025-03-06 DOI: 10.1016/j.ijcrp.2025.200380
John Patrick C. Toledo
{"title":"Digital self-assessment: A new and innovative way for identifying cardiovascular risks","authors":"John Patrick C. Toledo","doi":"10.1016/j.ijcrp.2025.200380","DOIUrl":"10.1016/j.ijcrp.2025.200380","url":null,"abstract":"","PeriodicalId":29726,"journal":{"name":"International Journal of Cardiology Cardiovascular Risk and Prevention","volume":"25 ","pages":"Article 200380"},"PeriodicalIF":1.9,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143580119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring sex-based differences in patient outcomes: A secondary analysis of Heartwatch, an Irish cardiovascular secondary prevention programme
IF 1.9
International Journal of Cardiology Cardiovascular Risk and Prevention Pub Date : 2025-03-01 DOI: 10.1016/j.ijcrp.2025.200376
Ivana Keenan , Fintan Stanley , Robyn Homeniuk , Joseph Gallagher , Michael O'Callaghan , Claire Collins
{"title":"Exploring sex-based differences in patient outcomes: A secondary analysis of Heartwatch, an Irish cardiovascular secondary prevention programme","authors":"Ivana Keenan ,&nbsp;Fintan Stanley ,&nbsp;Robyn Homeniuk ,&nbsp;Joseph Gallagher ,&nbsp;Michael O'Callaghan ,&nbsp;Claire Collins","doi":"10.1016/j.ijcrp.2025.200376","DOIUrl":"10.1016/j.ijcrp.2025.200376","url":null,"abstract":"<div><h3>Background</h3><div>In the last two decades, sex-related differences regarding cardiovascular diagnosis, treatment, and risk factors management have been reported. The current study aims to explore differences in cardiovascular outcomes among male and female patients attending the Irish secondary cardiovascular prevention programme - Heartwatch.</div></div><div><h3>Methods</h3><div>This is a retrospective observational study. Anonymous data was extracted from the Heartwatch database from 2003 to 2017. Cardiovascular risk factors were analysed at sign-up and at four years follow-ups. An 8-point aggregate risk score (CCare Score) was assessed to calculate targeted outcomes. Generalized estimating equations models were applied for data analysis.</div></div><div><h3>Results</h3><div>In total 8893 patients (77 % male) were included. Females exhibited a higher risk profile across all cardiovascular risk factors and were more likely to be off target than males at baseline and after 4 years of programme attendance [M to F odds ratios(95 % CI); systolic blood pressure: 1.35 (1.21–1.49), waist circumference: 2.11(1.89–2.36), physical activity: 1.72 (1.53–1.95)]. CCare scores also demonstrated the gap between male and female patients at baseline [mean(sd); M: 5.1(1.2), F: 4.8(1.2)] and after 4 years of structured care [mean(sd); M: 5.3(1.2), F: 4.9(1.2)]. Female patients were less likely to be prescribed aspirin and ACE inhibitors but more likely to be prescribed AT2 inhibitors, calcium channel blockers, and diuretics compared to male patients.</div></div><div><h3>Conclusions</h3><div>The Heartwatch programme has demonstrably improved patient care, however, the continuous underperformance of female patients necessitates further investigation to ensure appropriate and equitable secondary CVD prevention among the Irish population.</div></div>","PeriodicalId":29726,"journal":{"name":"International Journal of Cardiology Cardiovascular Risk and Prevention","volume":"24 ","pages":"Article 200376"},"PeriodicalIF":1.9,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143510405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Temporal trends and disparities in mortality from hypertensive heart disease with heart failure: A nationwide analysis (1999–2020)
IF 1.9
International Journal of Cardiology Cardiovascular Risk and Prevention Pub Date : 2025-02-14 DOI: 10.1016/j.ijcrp.2025.200378
Aman Goyal , Humza Saeed , Ajeet Singh , Abdullah , Wania Sultan , Zubair Amin , Hritvik Jain , Zainali Chunawala , Mohamed Daoud , Sourbha S. Dani
{"title":"Temporal trends and disparities in mortality from hypertensive heart disease with heart failure: A nationwide analysis (1999–2020)","authors":"Aman Goyal ,&nbsp;Humza Saeed ,&nbsp;Ajeet Singh ,&nbsp;Abdullah ,&nbsp;Wania Sultan ,&nbsp;Zubair Amin ,&nbsp;Hritvik Jain ,&nbsp;Zainali Chunawala ,&nbsp;Mohamed Daoud ,&nbsp;Sourbha S. Dani","doi":"10.1016/j.ijcrp.2025.200378","DOIUrl":"10.1016/j.ijcrp.2025.200378","url":null,"abstract":"<div><h3>Introduction</h3><div>By 2019, nearly 20 million people worldwide had hypertensive heart disease (HHD), resulting in over 1.1 million deaths and 21.5 million disability-adjusted life years (DALYs). Hypertension is a significant factor in heart failure (HF), contributing to about a quarter of cases, increasing to 68 % in older adults. This study examines mortality trends among patients in the United States (US) affected by HHD and HF.</div></div><div><h3>Methodology</h3><div>This study used Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) data from 1999 to 2020 to analyze deaths in the United States among adults aged 25 and older from HHD and (congestive) HF (ICD-10 code I11.0). Age-adjusted mortality rates (AAMRs) and annual percent change (APC) were calculated by year, sex, age groups, race/ethnicity, geographics, and urbanization status.</div></div><div><h3>Results</h3><div>Between 1999 and 2020, AAMRs increased from 3.7 to 13.5 per 100,000 population, with a steep increase from 2014 to 2020 (APC: 14.44; 95 % CI: 11.12 to 20.62). Men had slightly higher AAMRs than women (6.3 vs. 6.1). Additionally, AAMRs were highest among non-Hispanic (NH) Black individuals. Non-metropolitan areas had higher AAMRs than metropolitan areas (6.6 vs 6.2). The average AAMR during the COVID-19 pandemic (2020–2022) was nearly three times the pre-pandemic average (1999–2019).</div></div><div><h3>Conclusions</h3><div>Mortality from combined HHD and HF has risen since 1999, with higher rates among men, NH Black individuals, and those in non-metropolitan areas. Policy changes are needed to address these disparities and enhance healthcare equity.</div></div>","PeriodicalId":29726,"journal":{"name":"International Journal of Cardiology Cardiovascular Risk and Prevention","volume":"24 ","pages":"Article 200378"},"PeriodicalIF":1.9,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143452991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信